conference call, page-8

what we all need to understand is the FDA panel is made up of poeple.
Humans will always interpret issue's differently.
It is always going to be a long learning process for the team at QRX to get FDA approval and given the different interpretations expressed at the meeting over several issue's we have away to go.
However believe it or not we are now closer to approval than prior to this meeting.
14-0 you say is a resounding failure will it was never going to be 12-2 11-3 10-4 as human nature and the panels own provado make's sure of that.
The company still holds value in cash,IP and the growing learning experience with dealing with the FDA so throwing your shares away for 10-15cps seems a bit out there.
Its not all over yet.